Results for tag: "Head And Neck Cancer Drug"

The Head and Neck Cancer Drug market is a subset of the larger Oncology Drugs market. It includes drugs used to treat cancers of the head and neck, such as squamous cell carcinoma, salivary gland cancer, and nasopharyngeal cancer. These drugs are typically used in combination with radiation therapy and/or surgery to treat the cancer. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and monoclonal antibodies. The Head and Neck Cancer Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Roche. Other companies include Novartis, Eli Lilly, and GlaxoSmithKline. Show Less Read more